Unum Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch UMRX and buy or sell other stocks, ETFs, and their options commission-free!

About UMRX

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. 

CEO
Andrew R. Robbins, MBA
CEOAndrew R. Robbins, MBA
Employees
205
Employees205
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2014
Founded2014
Employees
205
Employees205

UMRX Key Statistics

Market cap
1.04B
Market cap1.04B
Price-Earnings ratio
-1.91
Price-Earnings ratio-1.91
Dividend yield
Dividend yield
Average volume
1.27M
Average volume1.27M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$12.61
52 Week high$12.61
52 Week low
$3.72
52 Week low$3.72

People also own

Based on the portfolios of people who own UMRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.